Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Vascular effects of bisphosphonates-a systematic review.

Santos LL, Cavalcanti TB, Bandeira FA.

Clin Med Insights Endocrinol Diabetes. 2012;5:47-54. doi: 10.4137/CMED.S10007. Epub 2012 Oct 25.

2.

Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review.

Peters SA, den Ruijter HM, Bots ML, Moons KG.

Heart. 2012 Feb;98(3):177-84. doi: 10.1136/heartjnl-2011-300747. Epub 2011 Nov 17. Review.

PMID:
22095617
3.
4.

Tight relations between coronary calcification and atherosclerotic lesions in the carotid artery in chronic dialysis patients.

Kurnatowska I, Grzelak P, Stefańczyk L, Nowicki M.

Nephrology (Carlton). 2010 Mar;15(2):184-9. doi: 10.1111/j.1440-1797.2009.01169.x.

PMID:
20470277
5.

Measurement of pulse wave velocity: site matters.

Tillin T, Chambers J, Malik I, Coady E, Byrd S, Mayet J, Wright AR, Kooner J, Shore A, Thom S, Chaturvedi N, Hughes A.

J Hypertens. 2007 Feb;25(2):383-9.

PMID:
17211245
6.

Risedronate: a new oral bisphosphonate.

Umland EM, Boyce EG.

Clin Ther. 2001 Sep;23(9):1409-21. Review.

PMID:
11589256
7.

Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis.

Stompór T, Rajzer M, Pasowicz M, Kraśniak A, Sułowicz W, Kawecka-Jaszcz K, Tracz W, Janda K, Tabor B, Kowalczyk-Michałek ME, Wójcik K, Konieczyńska M, Klimeczek P, Janusz-Grzybowska E.

Int J Artif Organs. 2006 Aug;29(8):736-44.

PMID:
16969750
9.

Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T.

Jaroszynski A, Czekajska-Chechab E, Drelich-Zbroja A, Zapolski T, Ksiazek A.

Nephrol Dial Transplant. 2009 Mar;24(3):1003-8. doi: 10.1093/ndt/gfn581. Epub 2008 Oct 31.

10.

New bisphosphonates in the treatment of bone diseases.

Gatti D, Adami S.

Drugs Aging. 1999 Oct;15(4):285-96. Review.

PMID:
10582775
11.

Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis.

Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H.

Am J Kidney Dis. 2004 Oct;44(4):680-8.

PMID:
15384019
12.

Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial.

Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG.

Am J Kidney Dis. 2010 Jul;56(1):57-68. doi: 10.1053/j.ajkd.2009.12.039. Epub 2010 Mar 29.

PMID:
20347511
13.

Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis.

Delibasi T, Emral R, Erdogan MF, Kamel N.

Adv Ther. 2007 Mar-Apr;24(2):319-25.

PMID:
17565922
14.
15.

Carotid intima-media thickness, carotid distensibility and mitral, aortic valve calcification: a useful diagnostic parameter of systemic atherosclerotic disease.

Sgorbini L, Scuteri A, Leggio M, Gianni W, Nevola E, Leggio F.

J Cardiovasc Med (Hagerstown). 2007 May;8(5):342-7.

PMID:
17443100
16.

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Fleurence RL, Iglesias CP, Johnson JM.

Pharmacoeconomics. 2007;25(11):913-33. Review.

PMID:
17960951
17.

HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies.

Hulten E, Mitchell J, Scally J, Gibbs B, Villines TC.

Heart. 2009 Nov;95(22):1826-35. doi: 10.1136/hrt.2009.177774. Epub 2009 Jul 23. Review.

PMID:
19632982
18.

Etidronate and alendronate in the treatment of postmenopausal osteoporosis.

Beauchesne MF, Miller PF.

Ann Pharmacother. 1999 May;33(5):587-99. Review.

PMID:
10369624
19.
20.

Bisphosphonates: preclinical aspects and use in osteoporosis.

Fleisch HA.

Ann Med. 1997 Feb;29(1):55-62. Review.

PMID:
9073324
Items per page

Supplemental Content

Write to the Help Desk